Tag: health
‘Narratives of delay’: How the animal pharma industry resists moves to...
A DeSmog review of hundreds of documents identifies eight arguments fielded by the industrial farming lobby to allay concerns over livestock drugs.
$6 billion in PhRMA Network grants flood the non-profit world, muddying...
An analysis of the $6 billion in grants distributed by PhRMA and its member companies.
Crossing state lines for care: Kate Cox’s forced journey from Texas...
Cox's case spotlights the intense legal and ethical debates surrounding abortion in America today.
Texas high court blocks emergency abortion: A fight for reproductive rights...
Kate Cox's legal battle highlights the struggle against restrictive abortion laws in Texas.
EPA announces Lead and Copper Rule Improvements proposal to remove lead...
The proposal requires states, water utilities, and communities to locate lead water service lines, then utility companies are tasked with replacing a minimum of 10 percent of the lead water pipes every year to reach completion within the 10-year time frame.
Sick of outrageously excessive CEO compensation?
America’s top health care execs would rather we not.
The veiled threat of fiscal commission as gateway to Social Security...
In a controversial move, the GOP-led House Budget Committee's hearing to establish a fiscal commission raises alarms for potential cuts in Social Security and Medicare, sparking widespread criticism and concerns for the future of these essential programs.
Privatized prison healthcare in the US—profiteering at the expense of inmate...
Profiting from pain—the harsh reality of privatized prison healthcare in America.
Baltimore joins over 100 US cities in official endorsement of Medicare...
The resolution is seen as a step toward addressing health inequities and improving outcomes for all residents in Baltimore and beyond.
How a big pharma company stalled a potentially lifesaving vaccine in...
A vaccine against tuberculosis, the world’s deadliest infectious disease, slowed after its corporate owner focused on more profitable vaccines.